News
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services ...
This compares to the stock's 8% gain over the past four weeks. Elevance Health’s share price benefited from investors seeking stability amid heightened market volatility. A sharp sell-off in ...
Truist Financial dropped their price target on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Argus upgraded ...
Elevance Health shares opened at $410.42 on the New York Stock Exchange Tuesday, up 0.9% from the previous closing price. Elevance Health cited elevated Medicare Advantage costs due to ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
1d
Elevance Health posts strong Q1 with premium, Medicare, and CarelonRx growth, reaffirming 2025 EPS guidance above Wall Street estimates.
Health insurer Elevance Health spent less-than-expected on medical care in the first quarter and beat profit estimates, days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback